Super-Enhancers in Placental Development and Diseases
Gracy X. Rosario,
No information about this author
Sam P. Brown,
No information about this author
Subhradip Karmakar
No information about this author
et al.
Journal of Developmental Biology,
Journal Year:
2025,
Volume and Issue:
13(2), P. 11 - 11
Published: April 9, 2025
The
proliferation
of
trophoblast
stem
(TS)
cells
and
their
differentiation
into
multiple
lineages
are
pivotal
for
placental
development
functions.
Various
transcription
factors
(TFs),
such
as
CDX2,
EOMES,
GATA3,
TFAP2C,
TEAD4,
along
with
binding
sites
cis-regulatory
elements,
have
been
studied
roles
in
cells.
While
previous
studies
primarily
focused
on
individual
enhancer
regions
differentiation,
recent
attention
has
shifted
towards
investigating
the
role
super-enhancers
(SEs)
different
cell
lineages.
SEs
clusters
regulatory
elements
enriched
transcriptional
regulators,
forming
complex
gene
networks
via
differential
patterns
synchronized
stimulation
target
genes.
Although
exact
remains
unclear,
they
commonly
found
near
master
regulator
genes
specific
types
implicated
regulation
tissue-specific
lineage
determination.
Additionally,
play
a
crucial
regulating
cellular
growth
both
normal
disease
pathologies.
This
review
summarizes
advances
SEs'
pathophysiology
diseases,
emphasizing
potential
identifying
SE-driven
placenta
to
provide
valuable
insights
developing
therapeutic
strategies
address
dysfunctions.
Language: Английский
Cell therapy with placenta-derived mesenchymal stem cells for secondary progressive multiple sclerosis patients in a phase 1 clinical trial
Ameneh Shokati,
No information about this author
Mohsen Nikbakht,
No information about this author
Mohammad Ali Sahraian
No information about this author
et al.
Scientific Reports,
Journal Year:
2025,
Volume and Issue:
15(1)
Published: May 8, 2025
Language: Английский
The culture and identification of human placenta-derived mesenchymal stem cells
Deleted Journal,
Journal Year:
2024,
Volume and Issue:
unknown, P. 1 - 6
Published: Nov. 20, 2024
Objective:
This
study
aimed
to
establish
a
reliable
protocol
for
the
cultivation
and
characterization
of
human
placenta-derived
mesenchymal
stem
cells
(hPMSCs)
evaluate
their
growth
dynamics
immunophenotype.
Methods:
hPMSCs
were
thawed
cultured
under
controlled
conditions
using
specialized
serum-free
medium.
Cell
viability
morphology
assessed
an
inverted
microscope,
medium
changes
performed
bi-daily.
For
cell
identification,
immunofluorescence
staining
was
conducted
with
antibodies
CD44,
CD90,
CD45,
characterized
based
on
surface
marker
expression.
Results:
Cultured
exhibited
fibroblast-like
rapid
proliferation,
particularly
after
reaching
seeding
density
50%.
Growth
curves
indicated
peak
proliferation
between
days
3
4.
Immunofluorescence
analysis
confirmed
that
positive
CD90
but
negative
aligning
typical
profiles.
Conclusion:
The
established
successfully
cultivated
hPMSCs,
demonstrating
specific
markers.
These
findings
support
potential
application
in
regenerative
medicine
therapeutic
research.
Language: Английский